Christopher D. Green wrote:
NYT reports (that /Nature/ reports) that Lilly has a new class of drugs
for schizophrenia.
http://www.nytimes.com/2007/09/03/business/03drug.html?hp
Chris
I pause to note that this report appears in the Business section instead
of the Science or Health section.
Ken
---------------------------------------------------------------
Kenneth M. Steele, Ph.D. [EMAIL PROTECTED]
Department of Psychology http://www.psych.appstate.edu
Appalachian State University
Boone, NC 28608
USA
---------------------------------------------------------------
---
